Seres therapeutics presents data at the 2025 digestive disease week conference highlighting the potential for live biotherapeutics to treat inflammatory and immune diseases

Cambridge, mass., april 29, 2025 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb), a leading live biotherapeutics company, today announced that it will present three related posters at the upcoming 2025 digestive disease week (ddw) conference being held may 3-6, 2025, in san diego, ca.
MCRB Ratings Summary
MCRB Quant Ranking